Euvichol-S: WHO Approves New Oral Cholera Vaccine
The World Health Organization (WHO) recently approved Euvichol-S, a new oral cholera vaccine developed by EuBiologics Co., Ltd. in South Korea. Euvichol-S simplifies the formulation…
The World Health Organization (WHO) recently approved Euvichol-S, a new oral cholera vaccine developed by EuBiologics Co., Ltd. in South Korea. Euvichol-S simplifies the formulation…
The Longevity India Initiative, spearheaded by the Indian Institute of Science, aims to revolutionize ageing research in India. This comprehensive project involves a large-scale clinical…
Premium Content! You need General Studies (GS) subscription to access this content. Join now to unlock premium content. JOIN NOW
Premium Content! You need General Studies (GS) subscription to access this content. Join now to unlock premium content. JOIN NOW
The Saksham App, launched by the Election Commission of India, is designed to support elderly voters and persons with disabilities, facilitating easier access to voting…
The Men5CV vaccine, recently introduced in Nigeria, marks a significant advancement in the global fight against meningitis. This innovative vaccine, known as MenFive, is capable…
Chagas disease, caused by the Trypanosoma cruzi parasite and spread by triatomine bugs, is a significant public health concern, particularly in Latin America. World Chagas…
Premium Content! You need General Studies (GS) subscription to access this content. Join now to unlock premium content. JOIN NOW
Please confirm you want to block this member.
You will no longer be able to:
Please allow a few minutes for this process to complete.